UBS’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$32K Buy
1,354
+342
+34% +$7.88K ﹤0.01% 7407
2014
Q2
$28K Sell
1,012
-1,758
-63% -$45.3K ﹤0.01% 7665
2014
Q1
$79K Buy
2,770
+1,847
+200% +$56.9K ﹤0.01% 6291
2013
Q4
$26K Buy
923
+240
+35% +$9.65K ﹤0.01% 7840
2013
Q3
$30K Sell
683
-647
-49% -$21.3K ﹤0.01% 7557
2013
Q2
$28K Buy
+1,330
New +$17.6K ﹤0.01% 7483

Other funds holding HQCL

UBS's HQCL Position: Q3 2014 in Review

UBS increased its Hanwha Q CELLS Co., Ltd. (HQCL) stake by 34% in Q3 2014, buying an estimated $7.88K and bringing the position to 1,354 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #7407.

UBS first reported a position in HQCL in Q2 2013 and has held it in 6 quarters since. The position peaked at $79K in Q1 2014. 33 funds tracked by Wall St. Rank hold HQCL as of Q3 2014.

  • UBS held 1,354 shares of Hanwha Q CELLS Co., Ltd. worth $32K as of Q3 2014.
  • UBS bought 342 Hanwha Q CELLS Co., Ltd. shares in Q3 2014, an estimated $7.88K.
  • Hanwha Q CELLS Co., Ltd. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7407 holding.
  • UBS first reported a position in Hanwha Q CELLS Co., Ltd. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Hanwha Q CELLS Co., Ltd. position peaked at $79K in Q1 2014.
  • 33 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.